FDA approves Invokana to treat type 2 diabetes
The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.
-
Subscribe
Subscribe via the RSS feed